Is it safe, is it tolerable? Why not ask the patients? Kathy Redmond 1 September 2010 Editorial 0 Number 38 Download pdf article Many cancer medications are being prescribed by the month, year, or even indefinitely, tolerability is increasingly more important, yet patients have no direct input into evaluating a new drug. Download full article CTCAEEthan Baschside-effectsSymptom management
Cutting Edge Protecting patients’ nervous systems: Are we getting the care-cure balance right? Cutting Edge 1 May 2014 0
Patient Voice Side effects of targeted treatments: clinicians’ perceptions, patients’ realities Patient Voice 1 March 2015 0
Grandround Managing common toxicities with new tyrosine kinase inhibitors Grandround 1 December 2015 0
Leave a Reply